404
+1-313-307-4176
sales@stratviewresearch.com
Biodegradable Stents Market Report
Biodegradable Stents Market Size, Share, Trend, Forecast, & Competitive Analysis: 2022-2028
The Biodegradable Stents Market is estimated to grow from USD 316.41 million in 2021 to USD 589.37 million by 2028 at a healthy CAGR of 9.24% during the forecast period of 2022-2028.
A stent may be a medical device that's inserted into the inner duct of the body for expanding the blood vessels and preventing the vessels from blockage. Bio-absorbable stents also remarked as bio-resorbable stents or naturally-dissolving stents, are made from materials that get absorbed within the body and act by expanding the vessels or internal duct for clearing the blockage caused thanks to the deposition of plague.
The rise in the geriatric population, surge in percutaneous coronary intervention (PCI) procedure, growing prevalence of cardiovascular disease, and an increase in adaptation of bioabsorbable stents by patients and physicians are some of the major factors boosting the market growth. Moreover, strong growth in demand for minimally invasive procedures, advancement in technology in stents, and rise in the initiative taken by the government for the development & production of bioabsorbable stents further augment the industry growth.
The COVID-19 outbreak moderately affected the growth of the biodegradable stents market. With the surge in COVID-19 cases, healthcare professionals across geographies were focusing on treating corona-infected patients and other essential healthcare services. Additionally, the number of people visiting hospitals for non-emergency medical issues declined due to fear of infection.
Key players operating in the biodegradable stents market are-
Here is the list of the group of customers that the Biodegradable Stents Market hopes to have the greatest opportunity to convert-
Based on biomaterial, the market has been classified into polymeric stents and metallic stents. The polymeric stents segment accounted for a substantial market share in 2021. This is mainly ascribed to an increase in the usage of polymeric stents by several physicians, companies, and patients due to less inflammatory response, and low risk of associated complications. Also, research is still conducted on polymeric stent materials for the development of the novel bioabsorbable stents, which possess a low risk for restenosis and late-stent thrombosis, which further bolsters the segment growth.
The market in North America accounted for the largest share in 2021 and is projected to continue its dominance during the review period. This is mainly attributed to the surge in prevalence of cardiovascular disease, rise in the number of approval for novel bioabsorbable stents, the large presence of advanced healthcare infrastructure, as well as presence of major market participants. In addition, the surge in R&D activities in the healthcare sector and enhancement of healthcare infrastructure, and presence of major players operating in the region, which further proliferates the regional growth.
|
Report Feature |
|
|---|---|
|
Market Segmentation |
4 |
|
Regions Covered |
5 |
|
Countries/Subregions Covered |
16 |
|
Figures & Tables |
>90 |
|
Company Profile |
10 |
The market is segmented in the following ways:
For calculating the market size, our analysts follow either Top-Bottom or Bottom-Top approach or both, depending upon the complexity or availability of the data points. Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. We leverage multitude of authenticated secondary sources, such as company annual reports, government sources, trade associations, journals, investor presentation, white papers, and articles to gather the data. More than 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts are usually executed to obtain both qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market.
The following are the key features of the report:
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Custom Research: Stratview research offers custom research services across the sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The biodegradable stents market is expected to witness an impressive growth of 9.24% CAGR in the coming years.
Boston Scientific Corporation (US), Arterius Limited (UK), Elixir Medical Corporation (US), Kyo-to Medical Planning Co. Ltd (Japan), Terumo Corporation (Japan), Abbott Laboratories Inc. (US), Amaranth Medical (US), Biotronik (Germany), Meril Life Sciences Pvt. Ltd (India), and Reva Medical (US) are among the key players in the biodegradable stents market.
The biodegradable stents market size is expected to reach USD 589.37 million in 2028.
The polymeric stents segment accounted for a substantial share in the biodegradable stents market in 2021.
North America is expected to remain dominant in the biodegradable stents market in the next five years.
Biodegradable Stents distributors, Biodegradable Stents suppliers, Biodegradable Stents manufacturers, Hospitals, Government bodies are the target audience in the biodegradable stents market.
WE ACCEPT
